Cerity Partners’s Dare Bioscience DARE Stock Holding History

Cerity Partners’s Portfolio DARE Stock Details DARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-833	Closed	-$3.36K	–	2554
2024 Q2	$3.36K	Buy	+833	New	+$4.04K	﹤0.01%	2217

Other funds holding DARE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

FFS

Founders Financial Securities Towson, Maryland $1.77B AUM 17.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Cerity Partners's DARE Position: Q3 2024 in Review

Cerity Partners sold out of Dare Bioscience (DARE) in Q3 2024, closing a stake of 833 shares — an estimated $3.36K sold.

Cerity Partners first reported a position in DARE in Q2 2024 and held it in 1 quarter. The position peaked at $3.36K in Q2 2024. 22 funds tracked by Wall St. Rank hold DARE as of Q3 2024.

Cerity Partners reported no remaining Dare Bioscience position as of Q3 2024 after selling out during the quarter.
Cerity Partners sold 833 Dare Bioscience shares in Q3 2024, an estimated $3.36K.
Cerity Partners first reported a position in Dare Bioscience in Q2 2024 and held it in 1 quarter.
Cerity Partners's Dare Bioscience position peaked at $3.36K in Q2 2024.
22 funds tracked by Wall St. Rank held Dare Bioscience as of Q3 2024.

Based on Cerity Partners's 13F filing for Q3 2024, filed 12 Nov 2024.